Bastiaan Maes

Journal Article
A1
open access

A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19

Karel Van Damme (UGent) , Levi Hoste (UGent) , Jozefien Declercq (UGent) , Elisabeth De Leeuw (UGent) , Bastiaan Maes, Liesbet Martens (UGent) , Roos Colman (UGent) , Robin Browaeys (UGent) , Cedric Bosteels (UGent) , Stijn Verwaerde (UGent) , et al.

(2023) SCIENCE TRANSLATIONAL MEDICINE. 15(710).

Add to list

Journal Article
A1
open access

STE20 kinase TAOK3 regulates type 2 immunity and metabolism in obesity

Bastiaan Maes, Farzaneh Fayazpour (UGent) , Leen Catrysse (UGent) , Guillaume Lornet (UGent) , Evelien Van De Velde (UGent) , Caroline De Wolf (UGent) , Sofie De Prijck (UGent) , Justine Van Moorleghem (UGent) , Manon Vanheerswynghels (UGent) , Kim Deswarte (UGent) , et al.

(2023) JOURNAL OF EXPERIMENTAL MEDICINE. 220(9).

Add to list

PhD Thesis

TAOK3 regulates type 2 immune responses in the lung and adipose tissue

Bastiaan Maes

(2023)

Add to list

Miscellaneous
open access

A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19

Karel Van Damme (UGent) , Levi Hoste (UGent) , Jozefien Declercq (UGent) , Elisabeth De Leeuw (UGent) , Bastiaan Maes, Liesbet Martens (UGent) , Roos Colman (UGent) , Robin Browaeys (UGent) , Cedric Bosteels (UGent) , Stijn Verwaerde (UGent) , et al.

(2023) medRxiv.

Add to list

Journal Article
A1
open access

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment

Cedric Bosteels (UGent) , Karel Van Damme (UGent) , Elisabeth De Leeuw (UGent) , Jozefien Declercq (UGent) , Bastiaan Maes, Victor Bosteels (UGent) , Levi Hoste (UGent) , Leslie Naesens (UGent) , Nincy Debeuf (UGent) , Julie Deckers (UGent) , et al.

(2022) CELL REPORTS MEDICINE. 3(12).

Add to list

Journal Article
A1
open access

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19 : an open-label randomized controlled trial

Elisabeth De Leeuw (UGent) , Karel Van Damme (UGent) , Jozefien Declercq (UGent) , Cedric Bosteels (UGent) , Bastiaan Maes, Simon Tavernier (UGent) , Laurent Detalle, Trevor Smart, Sophie Glatt, Nincy Debeuf (UGent) , et al.

(2022) RESPIRATORY RESEARCH. 23(1).

Add to list

Journal Article
A1
open access

The STE20 kinase TAOK3 controls the development of house dust mite-induced asthma in mice

Bastiaan Maes, Ursula Smole (UGent) , Matthias Vanderkerken, Kim Deswarte (UGent) , Justine Van Moorleghem (UGent) , Karl Vergote (UGent) , Manon Vanheerswynghels (UGent) , Caroline De Wolf (UGent) , Sofie De Prijck (UGent) , Nincy Debeuf (UGent) , et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 149(4). p.1413-1427.e2

Add to list

Journal Article
A1
open access

TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C

Levi Hoste (UGent) , Lisa Roels (UGent) , Leslie Naesens (UGent) , Victor Bosteels (UGent) , Stijn Vanhee (UGent) , Sam Dupont (UGent) , Cedric Bosteels (UGent) , Robin Browaeys (UGent) , Niels Vandamme (UGent) , Kevin Verstaen (UGent) , et al.

(2022) JOURNAL OF EXPERIMENTAL MEDICINE. 219(2).

Add to list

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial

Jozefien Declercq (UGent) , Karel Van Damme (UGent) , Elisabeth De Leeuw (UGent) , Bastiaan Maes, Cedric Bosteels (UGent) , Simon Tavernier, Stefanie De Buyser (UGent) , Roos Colman (UGent) , Maya Hites, Gil Verschelden, et al.

(2021) LANCET RESPIRATORY MEDICINE. 9(12). p.1427-1438

Add to list

Journal Article
A1
open access

A20 deficiency in myeloid cells protects mice from diet-induced obesity and insulin resistance due to increased fatty acid metabolism

Leen Catrysse (UGent) , Bastiaan Maes, Parul Mehrotra (UGent) , Arne Martens (UGent) , Esther Hoste (UGent) , Liesbet Martens (UGent) , Christian Maueröder (UGent) , Anneleen Remmerie, Anna Bujko (UGent) , Karolina Slowicka (UGent) , et al.

(2021) CELL REPORTS. 36(12).

Academic Bibliography

Bastiaan Maes

A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19

STE20 kinase TAOK3 regulates type 2 immunity and metabolism in obesity

TAOK3 regulates type 2 immune responses in the lung and adipose tissue

A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19 : an open-label randomized controlled trial

The STE20 kinase TAOK3 controls the development of house dust mite-induced asthma in mice

TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial

A20 deficiency in myeloid cells protects mice from diet-induced obesity and insulin resistance due to increased fatty acid metabolism

Contents

Support

Contact